FREE SHIPPING ON ORDERS OVER £60 (UK)

Hifas da Terra develops a new product with positive impact on memory and cognitive deterioration

producto mejora memoria

Marta Hifas |

  • The results of a study in humans show important statistically significant changes in attention, memory, concentration, processing speed and viso-spatial skills
  • The essay has been developed in the final phase of the R&D project neurofood in which the functional food developed by Hifas da Terra and Cuevas y Cía has been tested
  • The fungi extracts selected for the product provided active compounds such as the natural neurotransmitter GABA and Ergotheonein, two substances with impact on the maintenance of cognition, stress and insomnia
Companies Hifas da Terra (HDT) and Cuevas and Cía have announced the results of the rehearsal carried out in the Foltra Health Center (Foltra Foundation) in which it is evident that the daily intake of a new functional food has an important impact in critical aspects of neurological health such as memory and attention, and can also be useful in the cognitive impairment associated with pathologies such as Alzheimer's. The presentation act "New functional foods and nutritional accessories oriented to neurocognitive development", celebrated virtually through the Zoom platform, was attended by the scientific director of Hifas da Terra, Dr. Esteban Sinde; the responsible for Quality Control in Cuevas y Cía, Blanco Church Tania; and, on behalf of the Foltra Health Center (Foltra Foundation), the Dr. Aurora Camacho and Don Carlos Agra, medical and responsible for neuropsychology, respectively. Likewise, the event was attended by representatives of the entities that make up the consortium formed for Neurofood, such as Sergio Baamonde López, Technical Responsible R&D Atlantic Algae Algamar, S. L L. The study details that all participants were evaluated through Neurological testss, before and after taking the developed product, which explore cognitive functions such as memory, orientation, memory, attention and processing speed, among others. Likewise, the work included evidence related to the cardiovascular area and nursing.

Medicinal fungi nutrients against neurocognitive decline

The product developed in the Neurofood project includes, among others, the selection of nutrients called “Mico Neuro”, with an important role for cognitive development and obtained naturally from the mane of León (Hericium Erinaceus) and Shiiitake (Edodes Lentinula), medicinal fungi cultivated and processed by Hifas da Terra. The initial phases of the innovation project allowed the selection of the most suitable species, as well as the optimization of cultivation processes that guarantee adequate levels of the natural neurotransmitter GABA and Ergotinein; Both substances with demonstrated activity on cognitive processes. In addition, in the Neurofood project, Hifas Da Terra researchers developed processes to increase GABA concentration, and could validate in vitro, with the collaboration of Anfaco, the functionality of some of the developments.

Trial results

The improvement indicators collected in the conclusions reveal that The product developed by Hifas da Terra y Cuevas and Cía can be useful for the general population and in people who must improve their neurocognitive development. In addition, the professionals of the Foltra Foundation said that the research carried out in the neurological field "They show the validity of the clinical protocol proposed by researchers in the short duration of the study".
  • Memory and concentration

The authors observed that, after the consumption of the neurofood product, the tests carried out in the neurological area evidenced a change very marked in skills related to memory, memory, immediate memory and the ability to concentrate.

  • Attention and processing speed

In addition, the participants in the study, after the intake of the product, managed to process more items in less time, which translates into better selective and sustained attention.

  • Viso-spatial skills

Another aspect highlighted in the conclusions of this study is the speed acquired by the subjects when executing the instructions given. Also, in general, participants improved their ability to inhibit or block distracting stimuli.

As explained by Dr. Esteban Sonde and Blanco Tania of the Church, the Neurofood product has been formulated from the conclusions obtained in the previous phases of the project that gives its name to this new development. In these, The suitable compounds that the product should contain were evaluated and both the concentration of bioactive substances and its biodisitability was optimized both. Foltra's medical manager, Dr. Camacho, added that the Neurofood product "It lacks adverse side effects, which thus expands the spectrum of application and security".

New research projects

Those responsible for this study agreed that these results allow new research paths in which the composition of the intestinal microbiota of the patients could be analyzed before and after the intake of the functional food. As Dr. Sinde recalled, scientific journals such as Journal of Alzheimer's DiseaseeitherSciences Advances, among others, they have recently published new evidences that relate, once again, the intestinal microbiota with neurological diseases. In this regard, he said, a correlation between intestinal microorganisms and the appearance of amyloid plaques in the brain has been established, which is considered a biomarker of Alzheimer's disease.

Test details

  • The essay was carried out with informed consent in 40 healthy volunteers of 53 years of the Foltra Foundation, a health center specialized in neurological rehabilitation.
  • The medical direction of the center developed the study in three phases in which aspects of the neurological, cardiovascular and nursing area were evaluated, before and after the intake of the product. During the same, organoleptic sensations and impressions of the tested product were also collected.
Hifas da Terra investigates the role of fungi in cancer and neurodegenerative, cardiovascular and autoimmune pathologies.